Hong Kong pharmaceutical company Uni-Bio Science listed in Hong Kong in 2001. Trading in its shares was suspended in March 2010 following a search of the company's property by the Independent Commission Against Corruption (ICAC) and subsequent arrest of two accounting staff. The next month, in April, the ICAC announced that it had charged Mr Liang, the alleged de facto controlling shareholder, for conspiring with others between August 2005 and July 2007 to defraud existing and potential investors in Uni-Bio by concealing the fact that he was the owner of three Chinese companies Uni-bio had acquired, and falsified accounting documents to inflate the value of the acquisitions. He was acquitted in March 2012. As such, the allegations were not proven.

Last updated December 2021

The information on this page has been compiled from publicly available sources. GMT Research Limited has not verified the information and does not warrant its accuracy. Any claims made or views expressed are not necessarily those of GMT Research Limited.